Amicus Therapeutics' solid Q3 results, new pipeline additions, and global expansion signal strong growth potential. Read the ...
Integrating nephrology and cardiology care for patients with kidney and cardiovascular (CV) risks can be challenging but is ...
Biomedical engineers at Duke University have shown that a genetic mutation that causes congenital heart disease also ...
It can be challenging to identify which patients with advanced chronic kidney disease (CKD) will most benefit from ...
Australian researchers are developing technology to enable timelier interventions and shift healthcare towards prevention rather than treatment.
Travere Therapeutics (TVTX) announced new data from the Phase 3 DUPLEX Study demonstrating that patients with focal segmental glomerulosclerosis ...
Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced new data from the Phase 3 DUPLEX Study demonstrating that patients with focal segmental glomerulosclerosis (FSGS) treated with FILSPARI® ...
Although rare kidney diseases remain a significantly overlooked contributor to the global burden of CKD, things have begun to ...
A new research initiative led by Monash University researchers, the Digital Health Cooperative Research Centre (DHCRC), and Optain Health, will ...
A research team led by the Institute for Bioengineering of Catalonia (IBEC) and collaborating with the Biomedical Research ...
A machine learning model using basic clinical data can predict PH risk, identifying key predictors like low hemoglobin and elevated NT-proBNP. Researchers have developed a machine learning model that ...
The lab simulates real-life impacts to evaluate helmet performance, aiming to reduce concussions and chronic traumatic encephalopathy (CTE) risks. Tool or shortcut? 90% of students use ChatGPT as AI ...